icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
 
 
 
Continued Efficacy and Safety Through 4 Years of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg-Negative Patients with Chronic Hepatitis B (Study 102)
 
 
  Reported by Jules Levin
AASLD Oct 31 2010 Boston
 
P Marcellin1, M Buti2, Z Krastev3, S Gurel4, A M Di Bisceglie5, J A Odin6, G M Dusheiko7, E J Heathcote8, K Borroto-Esoda9, D H Coombs9, E Mondou9, J Anderson9 1Hopital Beaujon, University of Paris, Clichy, France; 2Servicio de Medicina Interna Hepatologia, Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain; 3University Hospital "St. Ivan Rilsky", Sofi a, Bulgaria; 4University of Uludag, Bursa, Turkey; 5Saint Louis University School Of Medicine, St. Louis, MO, USA; 6Mount Sinai School of Medicine, New York , NY, USA; 7Royal Free Hospital , London, UK; 8University of Toronto, Toronto, ON, Canada; 9Gilead Sciences, Durham, NC, USA.